Medicinal Chemistry European Journal of Medicinal Chemistry
Glue degrader clears DNMT1 to ease liver fibrosis
- A dicyanopyridine-based glue degrader, C39, emerged from structure-guided optimization and removes DNMT1 protein in hepatic stellate cells with good potency and a fairly short half-life.
- In TGF-β1-activated LX-2 cells it dampened stellate cell activation and matrix accumulation.
- In a CCl4 mouse model it lowered liver injury, collagen deposition and α-SMA, and reduced pro-fibrotic M2-like macrophages and myeloid-derived suppressor cells.
A glue aimed at DNMT1 is a welcome alternative to nucleoside traps: decitabine-type drugs are incorporated into DNA, cause damage and are chemically unstable, whereas a glue works catalytically at the protein level. Before calling the stellate-cell phenotype on-target I'd want the E3/DCAF identity, proteome-wide selectivity (DNMT3A/3B, other methyltransferases) and a non-degrading analog control.
Paper: European Journal of Medicinal Chemistry ↗ Discovery of DNMT1-Targeting Molecular Glue Degraders with Potent Antifibrotic Efficacy Against Liver Fibrosis